Optherion, Inc
- The Maritime Center 11th Fl 555 Long Wharf Dr
- New Haven, Connecticut
- 06511
- Phone: 203.781.0072
- Website
Description
Optherion, Inc. is a biotechnology company that is developing diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration (AMD), dense deposit disease (DDD, also referred to as membranoproliferative glomerulonephritis [MPGN II]), atypical hemolytic uremic syndrome (aHUS), and other chronic diseases involving the alternative complement cascade.